BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37179448)

  • 1. The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.
    Olynyk JK; Grainger R; Currie H; Ramm LE; Ramm GA
    Sci Rep; 2023 May; 13(1):7775. PubMed ID: 37179448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A3-B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload.
    Olsson KS; Ritter B; Raha-Chowdhury R
    Eur J Haematol; 2010 Feb; 84(2):145-53. PubMed ID: 19912313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
    Barton JC; Barton JC; Acton RT
    Hereditas; 2022 Jun; 159(1):25. PubMed ID: 35659379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis.
    Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC
    Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
    Barton JC; Barton JC; Acton RT
    Eur J Haematol; 2010 Nov; 85(5):439-47. PubMed ID: 20722701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
    Barton JC; Bertoli LF; Acton RT
    Blood Cells Mol Dis; 2003; 31(1):102-11. PubMed ID: 12850493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA haplotypes associated with hemochromatosis mutations in the Spanish population.
    Pacho A; Mancebo E; del Rey MJ; Castro MJ; Oliver D; García-Berciano M; González L; Morales P
    BMC Med Genet; 2004 Oct; 5():25. PubMed ID: 15498100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
    Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
    Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
    Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
    J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload.
    Cruz E; Vieira J; Almeida S; Lacerda R; Gartner A; Cardoso CS; Alves H; Porto G
    BMC Med Genet; 2006 Mar; 7():16. PubMed ID: 16509978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
    Pilling LC; Atkins JL; Melzer D
    Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemochromatosis: association of severity of iron overload with genetic markers.
    Barton JC; Harmon L; Rivers C; Acton RT
    Blood Cells Mol Dis; 1996; 22(3):195-204. PubMed ID: 9075570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.